Canopy Growth Corp vs Meta Platforms Inc — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Meta Platforms Inc trades at $674.95 (market cap $1.68T). The key difference: Meta Platforms Inc is far larger — about 4216.2× Canopy Growth Corp's market cap, and Meta Platforms Inc pays a 0.32% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | META | |
|---|---|---|
Market Cap | $398.46M | $1.68T |
Sector | Health | Media |
52-Week High | $1.92 | $790.00 |
52-Week Low | $0.86 | $525.72 |
Enterprise Value | $337.90M | $1.68T |
Volume | — | 24,093,972 |
Dividend Yield | — | 0.32% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
META stock trades at $674.78, up 2.75% today, reflecting strong momentum near its recent highs. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $10.44 significantly exceeding expectations. Revenue growth remains solid, reaching $201.0B in 2025, while profitability metrics like a 32.84% net income margin and 32.93% ROE highlight operational efficiency. Technical indicators show a bullish trend with support at $655 and resistance at $678, though RSI levels suggest potential overbought conditions.
The outlook for META is positive, driven by AI innovations like Muse Spark and strong analyst consensus with a $815.44 price target. However, risks include ongoing litigation, such as the Massachusetts youth addiction lawsuit, and high capital expenditures in AI infrastructure. Investors should weigh the company's growth trajectory against regulatory and execution risks.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →